EMPIL–DOC Act

Bill: 116-hr-6829
Sponsor: full_name: Rep. Pappas, Chris [D-NH-1]
Introduced: 2020-05-12
Policy area: Health
Subjects: Cardiovascular and respiratory health

Computers and information technology

Drug safety, medical device, and laboratory regulation

Emergency medical services and trauma care

Health information and medical records

Health programs administration and funding

Health technology, devices, supplies

Immunology and vaccination

Infectious and parasitic diseases

International organizations and cooperation

Israel

Medical tests and diagnostic methods

Middle East
Latest action: action_date: 2020-05-12
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2020-05-12
action_desc: Introduced in House
text: <p><b>Expanding Medical Partnerships with Israel to Lessen Dependence on China Act or the EMPIL-DOC Act</b></p> <p>This bill authorizes a bilateral grant program with Israel to develop health technologies, with an emphasis on the use of technology, personalized medicine, and data in relation to COVID-19 (i.e., coronavirus disease 2019). Technologies to be developed through this program include, among others,&nbsp;artificial intelligence, respiratory assist devices, and diagnostic tests. </p> <p>In addition, the program conditions funding on a matching contribution from the government of Israel. </p>

tv_txt: I 116th CONGRESS 2d Session H. R. 6829 IN THE HOUSE OF REPRESENTATIVES May 12, 2020 Mr. Pappas (for himself, Mr. Gooden , Mr. Suozzi , and Mr. Kustoff of Tennessee ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To authorize funding for a bilateral cooperative program with Israel for the development of health technologies with a focus on combating COVID-19.

1. Short title This Act may be cited as the Expanding Medical Partnerships with Israel to Lessen Dependence on China Act or the EMPIL–DOC Act . 2. Bilateral cooperative agreement (a) Authorization of appropriations There is authorized to be appropriated to the Secretary of Health and Human Services $4,000,000 for each of fiscal years 2021 through 2023 for a bilateral cooperative program with the Government of Israel for awarding grants for the development of health technologies, including such technologies described in subsection (b), subject to subsection (c), with an emphasis on collaboratively advancing the use of technology, personalized medicine, and data in relation to COVID-19. (b) Types of health technologies The health technologies described in this subsection shall include technologies such as artificial intelligence, drugs and vaccinations, respiratory assist devices, diagnostic tests, and telemedicine. (c) Restrictions on funding The funding under subsection (a) is subject to a matching contribution from the Government of Israel. (d) Option for establishing new program The amounts appropriated under subsection (a) may be— (1) for a bilateral program with the Government of Israel that is in existence on the day before the date of enactment of this Act for the purposes described in such subsection; or (2) for a bilateral program with the Government of Israel that is established after the date of enactment of this Act by the Secretary of Health and Human Services, in consultation with the Secretary of State, in accordance with the Agreement between the Government of the United States of America and the Government of the State of Israel on Cooperation in Science and Technology for Homeland Security Matters, done at Jerusalem May 29, 2008 (or a successor agreement), for the purposes described in subsection (a).